Deep venous thrombosis: Difference between revisions

No edit summary
No edit summary
Line 46: Line 46:
#Arteritis
#Arteritis
#[[Paget-Schroetter Syndrome]]
#[[Paget-Schroetter Syndrome]]
==Disposition==
Consider admission for:
#Presence of massive DVT
##Phlegmasia alba dolens ("painful white edema")
###Some venous flow through superficial system
###Seen in pregnant women
##Phlegmasia cerulea dolens ("painful blue edema")
###Complete venous obstruction leads to venous congestion, which impedes arterial flow
##Venous gangrene
###Ultimate dreaded consequence in this spectrum due to ischemia
#Presence of concurrent symptoms of PE
#High-risk of anticoagulation-related bleeding
#Recent (within 2 weeks) stroke or transient ischemic attack
#Severe renal dysfunction (GFR < 30)
#History of heparin sensitivity or [[Heparin-Induced Thrombocytopenia]]
#Weight > 150kg


==Treatment==
==Treatment==
*Outpatient
'''Contraindications to A/C'''
**[[Enoxaparin]] 0.5 mg/kg subcutaneously X1 in ED by RN
* Active hemorrhage
**Enoxaparin 0.5 mg/kg subcutaneously X1 in ED by pt
* Plt < 50
**[[Coumadin]] 5 mg po x 1 in ED
* h/o intracerebral hemorrhage
**Enoxaparin 1mg/kg sc q12hr x 5 days
'''Proximal'''
**Warfarin 5mg PO daily (give 7 days worth only)
* If NO phlegmasia cerulea dolens:
**Arrange for 2-3 day follow-up in anticoagulation clinic
** Anticoagulate with heparin/coumadin x 3 months
*Inpatient
* If phlegmasia cerulea dolens:
**Warfarin AND
** Consider thrombolytics +/- thrombectomy
**Enoxaparin: 1 mg/kg SC q12hr OR 1.5mg/kg SC qday OR
** Anticoagulate with heparin/coumadin x 3 months
**[[Unfractionated Heparin]]: 80 units/kg bolus; then 18 units/kg/hr
* If A/C contraindicated:
** IVC filter
'''Distal'''
* Symptomatic
** Anticoagulate with heparin/coumadin x 3 months
* Asymptomatic with extension of thrombus toward proximal veins
** Anticoagulate with heparin/coumadin x 3 months
* Asymptomatic without extension
** d/c with compressive U/S q2weeks
'''Therapy'''
* Standard anticoagulation regimen
**[[Enoxaparin]] 1 mg/kg q12h 4-5 days
**[[Coumadin]]
***typical starting dose 5 mg/day
***give 7d supply with first dose in ED
* For pts with GFR < 30 and/or potentially requiring reversal
**[[Unfractionated Heparin]] 80 units/kg bolus then 18 units/kg/hour
***Check PTT after 6hr; adjust infusion to maintain PTT at 1.5-2.5x control
***Check PTT after 6hr; adjust infusion to maintain PTT at 1.5-2.5x control
** Coumadin as above
==Disposition==
'''Inpatient therapy for pts with ANY of the following:'''
* Iliofemoral DVT
* Phlegmasia cerulea dolens
* High risk of bleeding on A/C
* Significant comorbidities
* Symptoms of concurrent PE
* Recent (within 2 weeks) stroke or transient ischemic attack
* Severe renal dysfunction (GFR < 30)
* History of heparin sensitivity or [[Heparin-Induced Thrombocytopenia]]
* Weight > 150kg
'''Outpatient therapy for patients with ALL of the following:'''
* Ambulatory
* Hemodynamically stable
* Low risk of bleeding in patient
* Absence of renal failure
* Able to administer (or have administered) LMWH +/- coumadin with appropriate monitoring
Arrange for 2-3 day follow-up in anticoagulation clinic


==See Also==
==See Also==

Revision as of 18:56, 26 October 2014

Diagnosis

Modified Wells Score

  1. Active cancer (<6 mo) - 1pt
  2. Paralysis, paresis, or immob of extremity - 1pt
  3. Bedridden >3 d b/c of sx (w/in 4 wk) - 1pt
  4. TTP along deep venous system - 1pt
  5. Entire leg swollen - 1pt
  6. Unilateral calf swelling >3cm below tibial tuberosity - 1pt
  7. Unilateral pitting edema - 1pt
  8. Collateral superficial veins (not varicose) - 1pt
  9. Previously documented DVT - 1pt
  10. Alternative dx as likely or more likely than DVT - (-)2pts
DVT.jpeg

Probability

  • 0-1 = Low probability
  • ≥2 = High probability
Low Probability
  • Send d-dimer
    • If pos obtain utz
High Probability
  • Send d-dimer AND obtain utz
    • If both negative done
    • If utz positive done
    • If pos d-dimer but neg UTZ:
      • Repeat utz in 1wk

DDx

  1. Arterial embolism
  2. Septic Joint
  3. Osteomyelitis
  4. Compartment Syndrome
  5. Nec fasc
  6. Gout
  7. Neuropathy
  8. Nerve entrapment
  9. Sciatica
  10. Fracture
  11. Reflex Sympathetic Dystrophy
  12. Lymphangitis
  13. Buerger's disease
  14. Arthritis
  15. Tendonitis
  16. Myositis
  17. Arteritis
  18. Paget-Schroetter Syndrome

Treatment

Contraindications to A/C

  • Active hemorrhage
  • Plt < 50
  • h/o intracerebral hemorrhage

Proximal

  • If NO phlegmasia cerulea dolens:
    • Anticoagulate with heparin/coumadin x 3 months
  • If phlegmasia cerulea dolens:
    • Consider thrombolytics +/- thrombectomy
    • Anticoagulate with heparin/coumadin x 3 months
  • If A/C contraindicated:
    • IVC filter

Distal

  • Symptomatic
    • Anticoagulate with heparin/coumadin x 3 months
  • Asymptomatic with extension of thrombus toward proximal veins
    • Anticoagulate with heparin/coumadin x 3 months
  • Asymptomatic without extension
    • d/c with compressive U/S q2weeks

Therapy

  • Standard anticoagulation regimen
    • Enoxaparin 1 mg/kg q12h 4-5 days
    • Coumadin
      • typical starting dose 5 mg/day
      • give 7d supply with first dose in ED
  • For pts with GFR < 30 and/or potentially requiring reversal
    • Unfractionated Heparin 80 units/kg bolus then 18 units/kg/hour
      • Check PTT after 6hr; adjust infusion to maintain PTT at 1.5-2.5x control
    • Coumadin as above

Disposition

Inpatient therapy for pts with ANY of the following:

  • Iliofemoral DVT
  • Phlegmasia cerulea dolens
  • High risk of bleeding on A/C
  • Significant comorbidities
  • Symptoms of concurrent PE
  • Recent (within 2 weeks) stroke or transient ischemic attack
  • Severe renal dysfunction (GFR < 30)
  • History of heparin sensitivity or Heparin-Induced Thrombocytopenia
  • Weight > 150kg

Outpatient therapy for patients with ALL of the following:

  • Ambulatory
  • Hemodynamically stable
  • Low risk of bleeding in patient
  • Absence of renal failure
  • Able to administer (or have administered) LMWH +/- coumadin with appropriate monitoring

Arrange for 2-3 day follow-up in anticoagulation clinic

See Also

External Links

Source

Tintinalli

UpToDate